ArticleEuropean heart journal2017
Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on BOARD.
Article in European heart journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Peripartum cardiomyopathy: A systematic review of the literature.Clinical cardiology · 2018Pooled it
- Management of Peripartum Cardiomyopathy With and Without Bromocriptine: A Comparative Study.Cureus · 2026Article
- Article
- Peripartum Cardiomyopathy: Current Insights into Pathogenesis and Clinical Management: A Narrative Review.Journal of clinical medicine · 2026Review
- Peripartum cardiomyopathy in an intensive care unit setting.World journal of critical care medicine · 2026Review
- Acute left and right ventricular heart failure with transient myocardial edema in a 26-Year-old female patient with peripartum cardiomyopathy and clivus chordoma.The international journal of cardiovascular imaging · 2025Article
- Peripartum cardiomyopathy: a comprehensive and contemporary review.Heart failure reviews · 2024Review
- Pharmacological interventions for peripartum cardiomyopathy.The Cochrane database of systematic reviews · 2024Article
- Serum Proteomic Analysis of Peripartum Cardiomyopathy Reveals Distinctive Dysregulation of Inflammatory and Cholesterol Metabolism Pathways.JACC. Heart failure · 2023Article
- Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.ESC heart failure · 2023Article
- Long-Term Follow-Up of Mechanical Circulatory Support in Peripartum Cardiomyopathy (PPCM) Refractory to Medical Management: A Multicenter Study.Life (Basel, Switzerland) · 2022Article
- Anticoagulation in cardiomyopathy: unravelling the hidden threat and challenging the threat individually.ESC heart failure · 2021Review
- A Systematic Review of the Utility of Bromocriptine in Acute Peripartum Cardiomyopathy.Cureus · 2021Review
- Article
- Perhexiline treatment improves toxic effects of β-adrenergic receptor stimulation in experimental peripartum cardiomyopathy.ESC heart failure · 2021Article
- Review
- Detection and management of arrhythmias in peripartum cardiomyopathy.Cardiovascular diagnosis and therapy · 2020Review
- Outcome in German and South African peripartum cardiomyopathy cohorts associates with medical therapy and fibrosis markers.ESC heart failure · 2020Article
- What is new in the 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy?Wiener klinische Wochenschrift · 2020Review
- Management of Heart Failure and Cardiogenic Shock in Pregnancy.Current treatment options in cardiovascular medicine · 2019Review
Corrections and comments
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
28934838What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.